OnDosis
Birgitta Bolander is an experienced professional with extensive expertise in quality assurance and regulatory affairs within the medical device industry. Currently serving as Quality Assurance Manager at OnDosis since April 2022, Birgitta previously held positions including Medical Devices - Quality and Regulatory Affairs, Product Development from October 2021 to April 2022, and Head of Regulatory Affairs as well as Head of Quality & Regulatory Affairs at Oticon Medical from February 2020 to September 2021. Prior experience includes roles as Technical Product Manager and R&D Group Manager at Mölnlycke, and Quality & Regulatory Affairs Director at Breas Medical. Birgitta's career began at the Hospital of Borås, where responsibilities included IT Manager and Medical Engineer. Birgitta's educational background includes studies at Borås/Linköping Tekniska Gymnasium from 1980 to 1984.
This person is not in any teams
OnDosis
1 followers
OnDosis proprietary technology delivers flexible and individualized dosing of oral medicines formulated as micro units. They are focused on providing reassurance in disease management, supporting adherence and providing greater convenience for patients. OnDosis is currently developing products for individualized dosing in diseases with asignificant burden on patients and healthcare such as ADHD, pain management and immunosuppression for organ transplants. Hundreds of thousands of patients with these conditions could be helped by improved dosing, ultimately leading to improving health care outcomes.The flexibility of OnDosis technology provides the potential for application across several disease areas and patient segments where conventional tablets or capsules often does not provide a good fit for the patient or treatment goal.OnDosis was founded in 2017 and is headquartered in Gothenburg, Sweden, based on an idea that was spun-out from AstraZeneca, using technology based on development work initiated there. It was founded by GU Ventures and Martin Olovsson. OnDosis operates a network of strategic partners across all core functions including formulation and device development, IP, Regulatory and Business Development.